Xenon Pharmaceuticals Inc. (XENE) Stock Total Returns
Growth of $10,000 chart
2021-04-21 to 2026-04-21 to
$
%
%
Loading chart…
Investment Performance
Final Value
$31,023
Total Return
210.23%
CAGR
25.42%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +2.98% |
| Median | +0.17% |
| Best | +113.53% |
| Worst | -28.90% |
| % of Windows Positive | 50.8% |
1-Year (252 Trading Days)
| Average | +17.97% |
| Median | +9.62% |
| Best | +141.52% |
| Worst | -33.12% |
| % of Windows Positive | 67.5% |
3-Year (756 Trading Days)
| Average | +44.53% |
| Median | +23.07% |
| Best | +174.83% |
| Worst | -11.62% |
| % of Windows Positive | 89.8% |
Risk Metrics
| Maximum Drawdown | -43.59% |
| Average Drawdown | -15.22% |
| Drawdown Duration | 518 Trading Days |
| Sortino Ratio | 1.32 |
| Calmar Ratio | 0.58 |
| CVaR (5%) | -6.18% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | +25.84% (+113.02% ann.) | +$2583.67 | $0.00 | $0.00 | $0.00 |
| 2025 | +14.34% | +$1433.67 | $0.00 | $0.00 | $0.00 |
| 2024 | -14.89% | $1489.36 | $0.00 | $0.00 | $0.00 |
| 2023 | +16.81% | +$1681.46 | $0.00 | $0.00 | $0.00 |
| 2022 | +26.22% | +$2621.64 | $0.00 | $0.00 | $0.00 |
| 2021 | +103.12% | +$10312.09 | $0.00 | $0.00 | $0.00 |
| 2020 | +17.32% | +$1731.51 | $0.00 | $0.00 | $0.00 |
| 2019 | +107.77% | +$10776.55 | $0.00 | $0.00 | $0.00 |
| 2018 | +123.36% | +$12336.24 | $0.00 | $0.00 | $0.00 |
| 2017 | -63.31% | $6331.16 | $0.00 | $0.00 | $0.00 |
| 2016 | -4.23% | $422.89 | $0.00 | $0.00 | $0.00 |
| 2015 | -59.29% | $5929.11 | $0.00 | $0.00 | $0.00 |
| 2014 partial | +88.10% (+6059.98% ann.) | +$8809.52 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | November 5, 2014 – February 19, 2020 | +56.29% | +8.81% | +$5628.57 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -40.10% | -99.71% | $4009.58 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | -1.61% | -2.58% | $161.44 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | +137.08% | +126.81% | +$13707.98 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | +23.82% | +25.47% | +$2382.03 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | +15.20% | +7.93% | +$1520.11 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 21, 2026 | +40.68% | +23.98% | +$4068.35 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.